{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:57:44Z","timestamp":1770973064502,"version":"3.50.1"},"reference-count":33,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15029","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T11:42:56Z","timestamp":1744198976000},"page":"1-9","source":"Crossref","is-referenced-by-count":1,"title":["Non\u2011endemic non\u2011keratinizing nasopharyngeal carcinoma: Long\u2011term toxicity following chemoradiation"],"prefix":"10.3892","volume":"29","author":[{"given":"Julija","family":"Ristivojevic","sequence":"first","affiliation":[{"name":"Department of Radiotherapy for Solid Tumors and Hematological Malignancies, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasa","family":"Korda","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy for Solid Tumors and Hematological Malignancies, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vukac","family":"Vujanac","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy for Solid Tumors and Hematological Malignancies, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Nikitovic","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy for Solid Tumors and Hematological Malignancies, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Arsenijevic","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy for Solid Tumors and Hematological Malignancies, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"key20250513102037_b1-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20250513102037_b2-ol-29-6-15029","first-page":"65","article-title":"WHO Classification of Head and Neck Tumours","volume-title":"WHO Classification of Tumours","author":"El-Naggar","year":"2017","edition":"4th edition"},{"key":"key20250513102037_b3-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","article-title":"Chemotherapy and radiotherapy in nasopharyngeal carcinoma: An update of the MAC-NPC meta-analysis","volume":"16","author":"Blanchard","year":"2015","journal-title":"Lancet Oncol"},{"key":"key20250513102037_b4-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","article-title":"International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma","volume":"126","author":"Lee","year":"2018","journal-title":"Radiother Oncol"},{"key":"key20250513102037_b5-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J Clin Oncol"},{"key":"key20250513102037_b6-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/jnci\/djr432","article-title":"Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: Phase III randomized trial","volume":"103","author":"Chen","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"key20250513102037_b7-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/jnci\/dji084","article-title":"Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma","volume":"97","author":"Chan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key20250513102037_b8-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.ijrobp.2008.05.023","article-title":"Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors","volume":"73","author":"Lee","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250513102037_b9-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/bjc.2013.720","article-title":"Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: Patient and treatment-related risk factors","volume":"110","author":"Zeng","year":"2014","journal-title":"Br J Cancer"},{"key":"key20250513102037_b10-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"E1026","DOI":"10.1002\/hed.24150","article-title":"Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy","volume":"38","author":"Huang","year":"2016","journal-title":"Head Neck"},{"key":"key20250513102037_b11-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ijrobp.2019.03.043","article-title":"Locoregional control and mild late toxicity after reducing target volumes and radiation doses in patients with locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy (IC) followed by concurrent chemoradiotherapy: 10-year results of a phase 2 study","volume":"104","author":"Zhao","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250513102037_b12-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"key20250513102037_b13-ol-29-6-15029","article-title":"AJCC Cancer Staging Manual","author":"Edge","year":"2010","edition":"7th edition"},{"key":"key20250513102037_b14-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/jjco\/hyz052","article-title":"A review of head and neck cancer staging system in the TNM classification of malignant tumors (eight edition)","volume":"49","author":"Monden","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"key20250513102037_b15-ol-29-6-15029","article-title":"Prescribing, Recording, and Reporting Photon Beam Therapy","author":"ICRU Report 50","year":"1993"},{"key":"key20250513102037_b16-ol-29-6-15029","article-title":"Prescribing, Recording, and Reporting Photon Beam Therapy (Supplement to ICRU Report 50)","author":"ICRU Report 62","year":"1999"},{"key":"key20250513102037_b17-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00066-011-0015-x","article-title":"The ICRU Report 83: Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT)","volume":"188","author":"Hodapp","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"key20250513102037_b18-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0167-8140(95)01548-U","article-title":"RTOG\/EORTC","volume":"35","author":"Late effects consensus conference","year":"1995","journal-title":"Radiother Oncol"},{"key":"key20250513102037_b19-ol-29-6-15029","article-title":"Common Terminology Criteria for Adverse Events v4.0 (CTCAE)","author":"U.S. Department of Health and Human Services"},{"key":"key20250513102037_b20-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","article-title":"Evolution of treatment for nasopharyngeal cancer-success and setback in the intensity-modulated radiotherapy era","volume":"110","author":"Lee","year":"2014","journal-title":"Radiother Oncol"},{"key":"key20250513102037_b21-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.7314\/APJCP.2015.16.5.1897","article-title":"Acute toxicity in nasopharyngeal carcinoma patients treated with IMRT\/VMAT","volume":"16","author":"Ozdemir","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20250513102037_b22-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ijrobp.2018.05.060","article-title":"Long-term late toxicity, quality of life, and emotional distress in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy","volume":"102","author":"McDowell","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250513102037_b23-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1200\/JCO.2004.03.025","article-title":"How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire C30","volume":"22","author":"Fromme","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20250513102037_b24-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/jnci\/djg014","article-title":"National institutes of health state-of-the-science conference statement: Symptom management in cancer: Pain, depression, and fatigue, july 15\u201317, 2002","volume":"95","author":"Patrick","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"key20250513102037_b25-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.3390\/jcm9124095","article-title":"Radiation-induced salivary gland dysfunction: Mechanisms, therapeutics and future directions","volume":"9","author":"Jasmer","year":"2020","journal-title":"J Clin Med"},{"key":"key20250513102037_b26-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1111\/odi.13599","article-title":"IMRT versus 2D\/3D conformal RT in oropharyngeal cancer: A review of the literature and meta-analysis","volume":"27","author":"Alterio","year":"2021","journal-title":"Oral Dis"},{"key":"key20250513102037_b27-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomized controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20250513102037_b28-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.radonc.2013.03.006","article-title":"The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT","volume":"106","author":"Miah","year":"2013","journal-title":"Radiother Oncol"},{"key":"key20250513102037_b29-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0360-3016(00)01441-3","article-title":"A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results","volume":"49","author":"Chao","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250513102037_b30-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"38381","DOI":"10.18632\/oncotarget.5420","article-title":"Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost","volume":"6","author":"Ou","year":"2015","journal-title":"Oncotarget"},{"key":"key20250513102037_b31-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"e2113205","DOI":"10.1001\/jamanetworkopen.2021.13205","article-title":"Toxicity profiles and survival outcomes among patients with nonmetastatic nasopharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated radiation therapy","volume":"4","author":"Li","year":"2021","journal-title":"JAMA Netw Open"},{"key":"key20250513102037_b32-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1053-4296(03)00036-5","article-title":"Normal tissue effects: Reporting and analysis","volume":"13","author":"Bentzen","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"key20250513102037_b33-ol-29-6-15029","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.ijrobp.2019.08.040","article-title":"Reporting of late morbidity after radiation therapy in large prospective studies: A descriptive review of the current status","volume":"105","author":"Vittrup","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:20:42Z","timestamp":1747120842000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,4,9]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15029","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]}}}